DCF — BAPTIST HEALTH HARDIN
Enterprise Value: $-179.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-179.8M
Enterprise Value
$-69.0M
PV of Cash Flows
$-110.8M
PV of Terminal Value
$-178.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $473.3M | $-4.6M | -1.0% | $-24.6M | $-22.4M |
| Year 2 | $487.4M | $0.2M | 0.0% | $-20.5M | $-16.9M |
| Year 3 | $502.1M | $5.2M | 1.0% | $-16.1M | $-12.1M |
| Year 4 | $517.1M | $7.9M | 2.0% | $-14.0M | $-9.5M |
| Year 5 | $532.6M | $9.5M | 2.0% | $-13.1M | $-8.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-179.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$459.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.014679421834263328
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5